BioArctic AB (publ)
BRCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $257,352 | $615,995 | $228,291 | $23,146 |
| % Growth | -58.2% | 169.8% | 886.3% | – |
| Cost of Goods Sold | $26,984 | $89,627 | $74,326 | $55,067 |
| Gross Profit | $230,368 | $526,368 | $153,965 | -$31,921 |
| % Margin | 89.5% | 85.5% | 67.4% | -137.9% |
| R&D Expenses | $311,145 | $0 | $7,098 | $6,063 |
| G&A Expenses | $93,380 | $128,477 | $0 | $24,852 |
| SG&A Expenses | $148,841 | $172,183 | $148,665 | $24,852 |
| Sales & Mktg Exp. | $55,461 | $43,706 | $0 | $0 |
| Other Operating Expenses | -$1,104 | $22,477 | $0 | $0 |
| Operating Expenses | $458,882 | $273,728 | $161,903 | $107,932 |
| Operating Income | -$228,514 | $252,640 | -$17,442 | -$139,723 |
| % Margin | -88.8% | 41% | -7.6% | -603.7% |
| Other Income/Exp. Net | $38,995 | $23,846 | $6,168 | -$788 |
| Pre-Tax Income | -$189,519 | $276,486 | -$11,167 | -$140,511 |
| Tax Expense | -$12,440 | $47,237 | $11 | -$20,723 |
| Net Income | -$177,079 | $229,249 | -$11,179 | -$119,789 |
| % Margin | -68.8% | 37.2% | -4.9% | -517.5% |
| EPS | -2 | 2.59 | -0.13 | -1.36 |
| % Growth | -177.2% | 2,092.3% | 90.4% | – |
| EPS Diluted | -2 | 2.59 | -0.13 | -1.36 |
| Weighted Avg Shares Out | 88,329 | 88,513 | 88,074 | 88,060 |
| Weighted Avg Shares Out Dil | 88,329 | 88,487 | 88,074 | 88,060 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40,845 | $34,228 | $2,535 | $0 |
| Interest Expense | $1,849 | $379 | $559 | $838 |
| Depreciation & Amortization | $18,428 | $18,428 | $14,633 | $13,107 |
| EBITDA | -$211,190 | $295,241 | $4,025 | -$126,566 |
| % Margin | -82.1% | 47.9% | 1.8% | -546.8% |